IN192747B - - Google Patents

Info

Publication number
IN192747B
IN192747B IN459DE2002A IN192747B IN 192747 B IN192747 B IN 192747B IN 459DE2002 A IN459DE2002 A IN 459DE2002A IN 192747 B IN192747 B IN 192747B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Manish Chawla
Rajeev Singh Raghuvanshi
Ashok Rampal
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN459DE2002 priority Critical patent/IN192747B/en
Priority to US10/511,486 priority patent/US20060165779A1/en
Priority to MXPA04010121A priority patent/MXPA04010121A/es
Priority to CA002482646A priority patent/CA2482646A1/en
Priority to AU2003216620A priority patent/AU2003216620A1/en
Priority to BR0309298-4A priority patent/BR0309298A/pt
Priority to EP03712530A priority patent/EP1499301A2/en
Priority to PCT/IB2003/001416 priority patent/WO2003086362A2/en
Publication of IN192747B publication Critical patent/IN192747B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
IN459DE2002 2002-04-15 2002-04-15 IN192747B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IN459DE2002 IN192747B (it) 2002-04-15 2002-04-15
US10/511,486 US20060165779A1 (en) 2002-04-15 2003-04-15 Novel method stabilizing bupropion hydrochloride tablets
MXPA04010121A MXPA04010121A (es) 2002-04-15 2003-04-15 Un metodo para estabilizar tabletas de clorhidrato de bupropion.
CA002482646A CA2482646A1 (en) 2002-04-15 2003-04-15 Method of stabilizing bupropion hydrochloride tablets
AU2003216620A AU2003216620A1 (en) 2002-04-15 2003-04-15 Method of stabilizing bupropion hydrochloride tablets
BR0309298-4A BR0309298A (pt) 2002-04-15 2003-04-15 Método para estabilizar comprimidos de cloreto de bupropion
EP03712530A EP1499301A2 (en) 2002-04-15 2003-04-15 Method of stabilizing bupropion hydrochloride tablets
PCT/IB2003/001416 WO2003086362A2 (en) 2002-04-15 2003-04-15 Method of stabilizing bupropion hydrochloride tablets

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN459DE2002 IN192747B (it) 2002-04-15 2002-04-15

Publications (1)

Publication Number Publication Date
IN192747B true IN192747B (it) 2004-05-15

Family

ID=29227524

Family Applications (1)

Application Number Title Priority Date Filing Date
IN459DE2002 IN192747B (it) 2002-04-15 2002-04-15

Country Status (8)

Country Link
US (1) US20060165779A1 (it)
EP (1) EP1499301A2 (it)
AU (1) AU2003216620A1 (it)
BR (1) BR0309298A (it)
CA (1) CA2482646A1 (it)
IN (1) IN192747B (it)
MX (1) MXPA04010121A (it)
WO (1) WO2003086362A2 (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1686974A1 (en) * 2003-11-21 2006-08-09 Ranbaxy Laboratories Limited Extended release dosage forms of bupropion hydrochloride
WO2007002597A2 (en) * 2005-06-27 2007-01-04 Biovail Laboratories International S.R.L. Modified-release formulations of a bupropion salt
US8703191B2 (en) 2006-07-25 2014-04-22 Intelgenx Corp. Controlled-release pharmaceutical tablets
WO2008038155A2 (en) * 2006-07-25 2008-04-03 Intelgenx Corp. Controlled-release pharmaceutical tablets
US7674479B2 (en) 2006-07-25 2010-03-09 Intelgenx Corp. Sustained-release bupropion and bupropion/mecamylamine tablets
US20100055180A1 (en) * 2007-10-10 2010-03-04 Mallinckrodt Baker, Inc. Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
AU2008311289A1 (en) * 2007-10-10 2009-04-16 Avantor Performance Materials, Inc. Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
CN103261404B (zh) 2010-12-16 2017-06-09 默克专利有限公司 干的颗粒状细胞培养基
US11969421B2 (en) 2013-11-05 2024-04-30 Antecip Bioventures Ii Llc Bupropion as a modulator of drug activity
AU2021390502A1 (en) 2020-12-01 2023-06-22 Antecip Bioventures Ii Llc Bupropion and dextromethorphan for reduction of suicide risk in depression patients
US11717518B1 (en) * 2022-06-30 2023-08-08 Antecip Bioventures Ii Llc Bupropion dosage forms with reduced food and alcohol dosing effects

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6033686A (en) * 1998-10-30 2000-03-07 Pharma Pass Llc Controlled release tablet of bupropion hydrochloride
CA2259730A1 (en) * 1999-01-18 2000-07-18 Bernard Charles Sherman Sustained release tablets containing bupropion hydrochloride
US6306436B1 (en) * 2000-04-28 2001-10-23 Teva Pharmaceuticals Usa, Inc. Stabilized, acid-free formulation for sustained release of bupropion hydrochloride
ITMI20011457A1 (it) * 2001-07-09 2003-01-09 Valpharma Sa Composizione farmaceutica a rilascio modificato contenente bupropionehc1 come sostanza attiva

Also Published As

Publication number Publication date
AU2003216620A8 (en) 2003-10-27
MXPA04010121A (es) 2004-12-13
US20060165779A1 (en) 2006-07-27
WO2003086362A2 (en) 2003-10-23
BR0309298A (pt) 2005-02-22
AU2003216620A1 (en) 2003-10-27
CA2482646A1 (en) 2003-10-23
EP1499301A2 (en) 2005-01-26
WO2003086362A3 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
BE2019C547I2 (it)
BE2019C510I2 (it)
BE2018C021I2 (it)
BE2017C049I2 (it)
BE2017C005I2 (it)
BE2016C069I2 (it)
BE2016C040I2 (it)
BE2016C013I2 (it)
BE2018C018I2 (it)
BE2016C002I2 (it)
BE2015C078I2 (it)
BE2015C017I2 (it)
BE2014C053I2 (it)
BE2014C051I2 (it)
BE2014C041I2 (it)
BE2014C030I2 (it)
BE2014C016I2 (it)
BE2014C015I2 (it)
BE2013C063I2 (it)
BE2013C039I2 (it)
BE2011C038I2 (it)
BE2013C046I2 (it)
IN192747B (it)
JP2003107136A5 (it)
JP2003217643A5 (it)